Software revolution for clinical trials
Health Tech Start-up Carelane Raises €800,000 in Pre-Seed Funding
Carelane
Clinical trials today face inefficiencies and high costs because they are reliant on multiple disjointed software systems for essential tasks such as data management, eConsent, tokenization, sample tracking, drug supply, and patient follow-up. The time required for integration and the challenges of process orchestration, along with regulatory compliance demands for unified audit trails, further complicate the situation.
Carelane uniquely integrates these features into a single platform, significantly reducing the complexity and expense associated with traditional clinical trial management. With Carelane, study protocols are structured, digitized documents rather than text-based, enabling seamless integration and continuous alignment of study design, conduct, and analysis. This approach avoids costly amendments that can cost millions of dollars.
The platform not only enhances security using the latest cloud technologies but also includes features for managing common trial processes such as sample shipments, site onboarding, and patient consents. All of this is achieved while maintaining a unified audit trail.
With this new capital, Carelane will broaden its reach across Europe and the United States. The start-up already demonstrated substantial traction before this funding round by reducing trial management burden by more than 80% for its initial customer through enhanced collaboration features and process automation. Looking ahead, Carelane plans to expand its platform with source data capture capabilities, including automatic data ingestion from electronic health records (EHRs) and AI features, setting the stage for a forthcoming seed funding round.
"Carelane offers a one-stop-shop platform focused on real world evidence research, addressing costly and inefficient clinical trials caused by fragmented software and a lack of integration between healthcare and clinical research systems. By unifying the entire clinical trial process in one platform, Carelane provides a strong value-proposition with benefits for both patients and research stakeholders", Dr. Natalya Baltrukovich, Investment Manager at HTGF.
"The study setup was highly intuitive and the time we saved on site selection and onboarding was impressive. By adapting the Carelane workflow templates and adding them to our study setup, we only needed to send out one email; everything else was automated. Our team quickly grasped how to build our case report form, which included complex fields with conditions and calculations. What really made a difference to me was the ability to invite collaborators and reviewers, it allowed them to comment on each individual item and accelerated the study setup tremendously", Prof. Dr. Martin Hoenigl, President of European Confederation of Medical Mycology (ECMM), Medical University of Graz.
"The system was very easy to use. Even without training, we could follow all the processes and complete tasks with ease", Prof. Dr. Emmanuel Roilides, Hippokration General Hospital.
Other news from the department business & finance
These products might interest you
Most read news
More news from our other portals
Something is happening in the life science industry ...
This is what true pioneering spirit looks like: Plenty of innovative start-ups are bringing fresh ideas, lifeblood and entrepreneurial spirit to change tomorrow's world for the better. Immerse yourself in the world of these young companies and take the opportunity to get in touch with the founders.